Medtronic Appeals Jury Verdict in Axonics Patent Dispute Over Bladder Control Device

Medtronic is challenging a recent federal jury verdict in California, which determined that Axonics did not infringe on three of its patents concerning a device used for bladder and bowel control. In response, Medtronic is seeking a new trial, contending that Axonics misled the jury to secure this outcome. Meanwhile, Axonics is advocating for the court to declare one of the patents in question invalid from the outset. The legal dispute highlights ongoing tensions and competitive challenges within the medical device industry. Further details on this evolving case can be found in the Law360 article.